Atlas Trials

A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy

Clinical trial NCT00424931 · COMPLETED

Trial details

NCT number
NCT00424931
Sponsor
Alza Corporation, DE, USA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Narcolepsy
Start date
2007-01-01
Primary completion
2007-11-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.